Arvinas
Developing protein-degrading therapies
- B2B
About Arvinas
Specializing in targeted protein degradation therapies to develop treatments for debilitating diseases by engineering PROTAC® protein degraders Visit wwwarvinascom for more info
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- New Haven, Connecticut, United States
- Founded
- 2013
- Revenue
- $263MFY2025, publicly reported
- Website
- arvinas.com
- linkedin.com/company/arvinas
Arvinas at a glance
Arvinas is a B2B company in the Biotechnology Research industry, headquartered in New Haven, Connecticut, United States.
Arvinas was founded in 2013.
Arvinas has 251–1,000 employees.
Arvinas's revenue is $263M (FY2025, publicly reported).
Selling to companies like Arvinas?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies